Pemanfaatan Glukosa Darah Puasa sebagai Pilar Edukasi dan Deteksi Dini Diabetes Melitus di Lingkungan Komunitas
DOI:
https://doi.org/10.58812/jpws.v5i06.3503Kata Kunci:
Gula Darah Puasa, Komunitas, PDCA, Diabetes, Lingkungan KomunitasAbstrak
Gangguan regulasi glukosa sering berkembang tanpa gejala pada populasi dewasa dan berkontribusi terhadap risiko penyakit metabolik. Kegiatan pengabdian kepada masyarakat ini menggunakan pendekatan Plan–Do–Check–Act (PDCA) untuk skrining gula darah puasa pada 109 partisipan dewasa. Pemeriksaan dilakukan dengan metode point-of-care testing (POCT) disertai edukasi kesehatan. Rerata usia partisipan adalah 42,81±13,55 tahun dengan dominasi perempuan (67,9%). Rerata kadar gula darah puasa sebesar 93,12±38,11 mg/dL dengan median 84 mg/dL (rentang 70–291 mg/dL). Sebagian besar partisipan berada dalam kategori normal (93,6%), sedangkan prediabetes dan diabetes masing-masing sebesar 2,8% dan 3,7%. Meskipun demikian, rentang nilai yang luas menunjukkan adanya heterogenitas status glikemik, termasuk nilai ekstrem yang mengindikasikan hiperglikemia bermakna. Skrining berbasis komunitas ini efektif dalam mendeteksi gangguan glikemik secara dini serta mendukung intervensi promotif-preventif melalui edukasi gaya hidup sehat.
Referensi
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024). Diabetes mellitus—Progress and opportunities in the evolving epidemic. Cell, 187(15), 3789–3820. https://doi.org/10.1016/j.cell.2024.06.029
Alexander Halim Santoso, Ernawati Ernawati, Sukmawati Tansil Tan, Yohanes Firmansyah, Dean Ascha Wijaya, & Fernando Nathaniel. (2023). Community Service Activities - Counseling And Random Blood Sugar Screening (Type 2 Diabetes Mellitus). Cakrawala: Jurnal Pengabdian Masyarakat Global, 2(2), 110–118. https://doi.org/10.30640/cakrawala.v2i2.1011
Asgari, S., Masrouri, S., Khalili, D., Azizi, F., & Hadaegh, F. (2022). Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.1018403
Brunetti, P., Baldessin, L., & Pagliacci, S. (2022). Prediabetes, undiagnosed diabetes and diabetes risk in Italy in 2017–2018: results from the first National screening campaign in community pharmacies. Journal of Public Health, 44(3), 499–506. https://doi.org/10.1093/pubmed/fdab046
Deepa, M., Anjana, R. M., Unnikrishnan, R., Pradeepa, R., Das, A. K., Madhu, S. V., Rao, P. V., Joshi, S., Saboo, B., Kumar, A., Bhansali, A., Gupta, A., Bajaj, S., Elangovan, N., Venkatesan, U., Subashini, R., Kaur, T., Dhaliwal, R. S., Tandon, N., … Ghosh, S. (2022). Variations in glycated haemoglobin with age among individuals with normal glucose tolerance: Implications for diagnosis and treatment—Results from the ICMR–INDIAB population-based study (INDIAB–12). Acta Diabetologica, 59(2), 225–232. https://doi.org/10.1007/s00592-021-01798-4
Han, J. A., Kim, S. J., Kim, G., Kim, E. J., & Lee, S. Y. (2016). Factors affecting screening for diabetic complications in the community: a multilevel analysis. Epidemiology and Health, 38, e2016017. https://doi.org/10.4178/epih.e2016017
Hilborne, L. H., Bi, C., Radcliff, J., Kroll, M. H., & Kaufman, H. W. (2022). Contributions of Glucose and Hemoglobin A1c Measurements in Diabetes Screening. American Journal of Clinical Pathology, 157(1), 1–4. https://doi.org/10.1093/ajcp/aqab106
Klimontov, V. V., & Semenova, J. F. (2022). Glucose variability in subjects with normal glucose tolerance: Relations with body composition, insulin secretion and sensitivity. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 16(1), 102387. https://doi.org/10.1016/j.dsx.2022.102387
Liu, Y., Guo, H., Wang, Q., Lian, D., Yang, M., Huang, K., Chen, J., Xuan, Y., Zhang, J., Wei, Q., Fang, S., Xu, J., Liu, Y., Sun, K., Sun, Z., & Wang, B. (2019). Use of capillary glucose combined with other non‐laboratory examinations to screen for diabetes and prediabetes. Diabetic Medicine, 36(12), 1671–1678. https://doi.org/10.1111/dme.14101
Norton, L., Shannon, C., Gastaldelli, A., & DeFronzo, R. A. (2022). Insulin: The master regulator of glucose metabolism. Metabolism, 129, 155142. https://doi.org/10.1016/j.metabol.2022.155142
Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., Lindstedt, P. A., Aali, A., Abate, Y. H., Abate, M. D., Abbasian, M., Abbasi-Kangevari, Z., Abbasi-Kangevari, M., Abd ElHafeez, S., Abd-Rabu, R., … Vos, T. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402(10397), 203–234. https://doi.org/10.1016/S0140-6736(23)01301-6
Ramaswamy, G., Chinnakali, P., Selvaraju, S., Nair, D., Thekkur, P., Selvaraj, K., Shivashankar, R., Singh, A. R., & Vrushabhendra, H. N. (2019). High prevalence of prediabetes among the family members of individuals with diabetes. Findings from targeted screening program from south India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(1), 866–872. https://doi.org/10.1016/j.dsx.2018.12.001
Sartore, G., Ragazzi, E., Caprino, R., & Lapolla, A. (2023). Long-term HbA1c variability and macro-/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update. Acta Diabetologica, 60(6), 721–738. https://doi.org/10.1007/s00592-023-02037-8
Setiawaty, S., Risma Dianti, A. R. D., & Noviyanti, S. R. (2022). Analisis Risiko dan Perilaku Pencegahan Penyakit DM Tipe 2 Pada Usia Produktif di Wilayah DKI Jakarta Tahun 2021. Journal of Public Health Education, 1(02), 82–90. https://doi.org/10.53801/jphe.v1i02.49
Shi, W., Wang, Q., Zhang, J., Zhang, J., Tan, F., & Yu, S. (2021). Incidence Tendency Analysis on Type 2 Diabetes in 4 Asian Countries — China, Malaysia, Singapore, and Thailand, 1990–2019. China CDC Weekly, 3(52), 1113–1117. https://doi.org/10.46234/ccdcw2021.268
Soares, M., & Müller, M. J. (2017). Type 2 diabetes in Asia: where do we go from here? European Journal of Clinical Nutrition, 71(7), 801–802. https://doi.org/10.1038/ejcn.2017.94
Sun, J., Hu, W., Ye, S., Deng, D., & Chen, M. (2023). The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes. Journal of Epidemiology and Global Health, 13(3), 566–576. https://doi.org/10.1007/s44197-023-00138-9
ter Horst, K. W., Gilijamse, P. W., Ackermans, M. T., Soeters, M. R., Nieuwdorp, M., Romijn, J. A., & Serlie, M. J. (2016). Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans. Metabolism, 65(5), 757–763. https://doi.org/10.1016/j.metabol.2016.02.010
Yang, W. (2013). Changing characteristics of the type 2 diabetes epidemic of China and other Asian countries. Journal of Diabetes Investigation, 4(3), 223–224. https://doi.org/10.1111/jdi.12057
Yapislar, H., & Gurler, E. B. (2024). Management of Microcomplications of Diabetes Mellitus: Challenges, Current Trends, and Future Perspectives in Treatment. Biomedicines, 12(9), 1958. https://doi.org/10.3390/biomedicines12091958
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Alfianto Martin, Alexander Halim Santoso
Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.
Facebook 
Instagram 
Twitter 
Youtube 
westscience.journals@gmail.com